(Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced an ...

Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today ...

Abstracts that are incomplete or received after the deadline will not be considered. All ESA Annual Meeting proposal and abstract deadlines are 5:00 PM Eastern so that technical support and ESA staff ...

All ESA Annual Meeting proposal and abstract deadlines are 5:00 PM Eastern so that technical support and ESA staff assistance will be immediately available when submitters need it. If you begin your ...

Abstracts accepted for presentation provide updates on ongoing EVEREST-2 clinical study and describe approaches to boost ...

DEL MAR, Calif., May 01, 2025--(BUSINESS WIRE)--Sydnexis, Inc., (www.sydnexis.com) a pre-commercial stage biopharmaceutical company, announces that three abstracts have been accepted for poster ...

The International Association for Food Protection’s program committee is inviting members and other interested individuals to submit proposals for abstracts and posters for IAFP 2021 meeting. The ...

TScan Therapeutics announced an accepted abstract for poster presentation at ASGCT's annual meeting on TCR-engineered therapies for cancer. TScan Therapeutics, Inc., a clinical-stage biotechnology ...

Hallux Announces Poster Exhibit Abstract ID 74740 on Dermatophytoma Treatment by HSG 42 in Phase 2a trial Available for ...

Laurel Hitchcock, PhD., Allison Shorten, PhD., Peter Bosworth, MBA., Shawn Galin, PhD, Tara Edmonds, PhD., Caroline Harada, MD., Using a Standardized Patient Model ...